Disease activity and LLDAS attainment during follow-up
| Mean (SD) or n (%) | |
|---|---|
| Duration of follow-up (years) | 3.90 (2.0) |
| Number of visits observed | 3352 |
| Visits per patient | 17.6 (11.7) |
| Interval between visits (days) | 86.2 (86.5) |
| SLEDAI-2K* | 4.0 (2.5) |
| PGA* | 0.58 (0.38) |
| Patients with at least one episode LLDAS | 169 (88.5%) |
| Number of visits where LLDAS achieved | 1107 |
| Number of visits in LLDAS (per patient) | 3.1 (4.5) |
| Total LLDAS duration per patient (years) | 1.6 (1.4) |
| Percentage time in LLDAS per patient | 39.6 (27.8) |
| Duration per LLDAS period (years) | 0.30 (0.25) |
*Averaged across all visits.
LLDAS, Lupus Low Disease Activity State; PGA, physician global assessment; SLEDAI, Systemic Lupus Erythematosus Disease Activity Index.